Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Antibiotic | Systematic Review

A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment

Authors: Salvatore Rotundo, Maria Teresa Tassone, Nadia Marascio, Helen Linda Morrone, Simona Gigliotti, Angela Quirino, Alessandro Russo, Giovanni Matera, Enrico Maria Trecarichi, Carlo Torti

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Cutaneous bacillary angiomatosis (cBA) is a vascular proliferative disorder due to Bartonella spp. that mostly affects people living with HIV (PLWH), transplanted patients and those taking immunosuppressive drugs. Since cBA is mostly related to these major immunocompromising conditions (i.e., T-cell count impairment), it is considered rare in relatively immunocompetent patients and could be underdiagnosed in them. Moreover, antimicrobial treatment in this population has not been previously investigated.

Methods

We searched the databases PubMed, Google Scholar, Scopus, OpenAIRE and ScienceDirect by screening articles whose title included the keywords “bacillary” AND “angiomatosis” and included case reports about patients not suffering from major immunocompromising conditions to provide insights about antibiotic treatments and their duration.

Results

Twenty-two cases of cBA not related to major immunocompromising conditions were retrieved. Antibiotic treatment duration was shorter in patients with single cBA lesion than in patients with multiple lesions, including in most cases macrolides and tetracyclines.

Conclusions

cBA is an emerging manifestation of Bartonella spp. infection in people not suffering from major immunocompromising conditions. Until evidence-based guidelines are available, molecular tests together with severity and extension of the disease can be useful to personalize the type of treatment and its duration.
Literature
1.
Adal KA, Cockerell CJ, Petri WAJNEJM Jr. Cat scratch disease, bacillary angiomatosis, and other infections due to Rochalimaea. 1994, 330(21):1509–15.
2.
Breitschwerdt EB. Bartonellosis, One Health and all creatures great and small. Vet Dermatol. 2017;28(1):96–e21.PubMedCrossRef
3.
Mullins K, Canal E, Ouch P, Prasetyo D, Tagoe J, Attram N, Yeboah C, Kumordjie S, Fox A, Letizia AG, et al. Bartonella Species in Cambodia, Ghana, Laos, and Peru: results from Vector and Serosurveys. Vector Borne Zoonotic Dis. 2023;23(1):9–17.PubMedCrossRef
4.
Koehler JE, Cederberg L. Intra-abdominal mass associated with gastrointestinal hemorrhage: a new manifestation of bacillary angiomatosis. Gastroenterology. 1995;109(6):2011–4.PubMedCrossRef
5.
Billeter SA, Levy MG, Chomel BB, Breitschwerdt EB. Vector transmission of Bartonella species with emphasis on the potential for tick transmission. Med Vet Entomol. 2008;22(1):1–15.PubMedCrossRef
6.
Regnery R, Tappero J. Unraveling mysteries associated with cat-scratch disease, bacillary angiomatosis, and related syndromes. Emerg Infect Dis. 1995;1(1):16–21.PubMedPubMedCentralCrossRef
7.
Reis C, Cote M, Le Rhun D, Lecuelle B, Levin ML, Vayssier-Taussat M, Bonnet SI. Vector competence of the tick Ixodes ricinus for transmission of Bartonella birtlesii. PLoS Negl Trop Dis. 2011;5(5):e1186.PubMedPubMedCentralCrossRef
8.
Bernabeu-Wittel J, Luque R, Corbi R, Mantrana-Bermejo M, Navarrete M, Vallejo A, Bernabeu-Wittel M. Bacillary angiomatosis with atypical clinical presentation in an immunocompetent patient. Indian J Dermatol Venereol Leprol. 2010;76(6):682–5.PubMedCrossRef
9.
Sanchez Clemente N, Ugarte-Gil CA, Solorzano N, Maguina C, Pachas P, Blazes D, Bailey R, Mabey D, Moore D. Bartonella bacilliformis: a systematic review of the literature to guide the research agenda for elimination. PLoS Negl Trop Dis. 2012;6(10):e1819.PubMedPubMedCentralCrossRef
10.
Huarcaya E, Best I, Rodriguez-Tafur J, Maguina C, Solorzano N, Menacho J, Lopez De Guimaraes D, Chauca J, Ventosilla P. Cytokines and T-Lymphocute count in patients in the acute and chronic phases of Bartonella bacilliformis infection in an endemic area in Peru: a pilot study. Rev Inst Med Trop Sao Paulo. 2011;53(3):149–54.PubMedCrossRef
11.
Zarraga M, Rosen L, Herschthal D. Bacillary angiomatosis in an immunocompetent child: a case report and review of the literature. Am J Dermatopathol. 2011;33(5):513–5.PubMedCrossRef
12.
Mogollon-Pasapera E, Otvos L Jr., Giordano A, Cassone M. Bartonella: emerging pathogen or emerging awareness? Int J Infect Dis. 2009;13(1):3–8.PubMedCrossRef
13.
Koehler JE, Sanchez MA, Garrido CS, Whitfeld MJ, Chen FM, Berger TG, Rodriguez-Barradas MC, LeBoit PE, Tappero JW. Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med. 1997;337(26):1876–83.PubMedCrossRef
14.
Agrawal S, Singal A, Arora VK. Bacillary Angiomatosis in an Immunocompetent patient: an unusual occurrence. Indian Dermatol Online J. 2022;13(4):527–9.PubMedPubMedCentralCrossRef
15.
16.
Karakas M, Baba M, Aksungur VL, Homan S, Memisoglu HR, Uguz A. Bacillary angiomatosis on a region of burned skin in a immunocompetent patient. Br J Dermatol. 2000;143(3):609–11.PubMedCrossRef
17.
Karakas M, Baba M, Homan S, Akman A, Acar MA, Memisoglu HR, Gumurdulu D. A case of bacillary angiomatosis presenting as leg ulcers. J Eur Acad Dermatol Venereol. 2003;17(1):65–7.PubMedCrossRef
18.
19.
Turgut M, Alabaz D, Karakas M, Kavak M, Aksaray N, Alhan E, Cevlik F, Tuncer I. Bacillary angiomatosis in an immunocompetent child with a grafted traumatic wound. J Dermatol. 2004;31(10):844–7.PubMedCrossRef
20.
Albayrak A, Albayrak Y, Unal D, Atasoy M, Uyanik MH. A case of bacillary angiomatosis developed at a burn site. Indian J Dermatol Venereol Leprol. 2012;78(1):121.PubMedCrossRef
21.
Balaban M, Ioana Nedelcu R, Balmes G, Adela Todorovic T, Brinzea A, Nichita L, Gabriela Popp C, Theodor Andrei R, Andrada Zurac S, Adriana Ion D, et al. Bacillary angiomatosis triggered by severe trauma in a healthy caucasian patient: a case report. Exp Ther Med. 2020;20(1):56–60.PubMed
22.
Tappero JW, Koehler JE, Berger TG, Cockerell CJ, Lee TH, Busch MP, Stites DP, Mohle-Boetani J, Reingold AL, LeBoit PE. Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med. 1993;118(5):363–5.PubMedCrossRef
23.
24.
Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://​aidsinfo.​nih.​gov/​contentfiles/​lvguidelines/​adult_​oi.​pdf. Accessed October 9, 2023.
25.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Group P-P: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.PubMedPubMedCentralCrossRef
26.
Gangopadhyay AK, Sharma PK. Bacillary angiomatosis in an immune-competent patient. Indian J Dermatol Venereol Leprol. 2001;67(1):37–8.PubMed
27.
Cockerell CJ, Bergstresser PR, Myrie-Williams C, Tierno PM. Bacillary epithelioid angiomatosis occurring in an immunocompetent individual. Arch Dermatol. 1990;126(6):787–90.PubMedCrossRef
28.
Iraji F, Pourazizi M, Abtahi-Naeini B, Meidani M, Rajabi P. Bacillary Angiomatosis in Immunocompetent patient with atypical manifestations. Indian J Dermatol. 2015;60(5):523.PubMedPubMedCentralCrossRef
29.
Paul MA, Fleischer AB Jr., Wieselthier JS, White WL. Bacillary angiomatosis in an immunocompetent child: the first reported case. Pediatr Dermatol. 1994;11(4):338–41.PubMedCrossRef
30.
Kayaselcuk F, Ceken I, Bircan S, Tuncer I. Bacillary angiomatosis of the scalp in a human immunodeficiency virus-negative patient. J Eur Acad Dermatol Venereol. 2002;16(6):612–4.PubMedCrossRef
31.
Smith KJ, Skelton HG, Tuur S, Larson PL, Angritt P. Bacillary angiomatosis in an immunocompetent child. Am J Dermatopathol. 1996;18(6):597–600.PubMedCrossRef
32.
Kacar N, Tasli L, Demirkan N, Ergin C, Ergin S. HIV-negative case of bacillary angiomatosis with chronic hepatitis B. J Dermatol. 2010;37(8):722–5.PubMedCrossRef
33.
Blattner C, Jacobson-Dunlop E, Miller JH, Elston DM. A case of bacillary angiomatosis in a patient with pancreatic adenocarcinoma. J Cutan Pathol. 2014;41(3):277–80.PubMedCrossRef
34.
Bellissimo-Rodrigues F, da Fonseca BA, Martinez R. Bacillary angiomatosis in a pregnant woman. Int J Gynaecol Obstet. 2010;111(1):85–6.PubMedCrossRef
35.
Omidian M, Ranjbari N, Omidian EJIJD. Bacillary angiomatosis in an immune competent patient: a case report from Iran. 2014, 17(1):39–41.
36.
Rotundo S, Bono F, Mazzitelli M, Scaglione V, Lamberti AG, Giancotti A, Tucci L, Costa C, Tassone MT, Morrone HL et al. An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: an emerging or overlooked disease? Int J Infect Dis 2023.
37.
38.
Valerio CR, Murray P, Arlian LG, Slater JE. Bacterial 16S ribosomal DNA in house dust mite cultures. J Allergy Clin Immunol. 2005;116(6):1296–300.PubMedCrossRef
39.
Murillo N, Mediannikov O, Aubert J, Raoult D. Bartonella quintana detection in Demodex from erythematotelangiectatic rosacea patients. Int J Infect Dis. 2014;29:176–7.PubMedCrossRef
40.
Jin X, Gou Y, Xin Y, Li J, Sun J, Li T, Feng J. Advancements in understanding the molecular and immune mechanisms of Bartonella pathogenicity. Front Microbiol. 2023;14:1196700.PubMedPubMedCentralCrossRef
41.
Lionello FCP, Rotundo S, Bruno G, Marino G, Morrone HL, Fusco P, Costa C, Russo A, Trecarichi EM, Beltrame A et al. Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the Magna Graecia University Unit of Infectious Diseases: A Didascalic Review. Diagnostics (Basel) 2023, 13(17).
42.
Malgorzata-Miller G, Heinbockel L, Brandenburg K, van der Meer JW, Netea MG, Joosten LA. Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications. Sci Rep. 2016;6:34221.PubMedPubMedCentralCrossRef
43.
Scutera S, Mitola S, Sparti R, Salvi V, Grillo E, Piersigilli G, Bugatti M, Alotto D, Schioppa T, Sozzani S, et al. Bartonella henselae persistence within mesenchymal stromal cells enhances endothelial cell activation and infectibility that amplifies the angiogenic process. Infect Immun. 2021;89(8):e0014121.PubMedCrossRef
44.
Kempf VA, Volkmann B, Schaller M, Sander CA, Alitalo K, Riess T, Autenrieth IB. Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Microbiol. 2001;3(9):623–32.PubMedCrossRef
45.
Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents. 2014;44(1):16–25.PubMedCrossRef
46.
Brenner EC, Chomel BB, Singhasivanon OU, Namekata DY, Kasten RW, Kass PH, Cortes-Vecino JA, Gennari SM, Rajapakse RP, Huong LT, et al. Bartonella infection in urban and rural dogs from the tropics: Brazil, Colombia, Sri Lanka and Vietnam. Epidemiol Infect. 2013;141(1):54–61.PubMedCrossRef
47.
Resto-Ruiz S, Burgess A, Anderson BE. The role of the host immune response in pathogenesis of Bartonella henselae. DNA Cell Biol. 2003;22(6):431–40.PubMedCrossRef
48.
Waldo E, Sidhu GS, Stahl R, Zolla-Pazner S. Histiocytoid hemangioma with features of angiolymphoid hyperplasia and Kaposi’s sarcoma. A study by light microscopy, electron microscopy, and immunologic techniques. Am J Dermatopathol. 1983;5(6):525–38.PubMedCrossRef
49.
Baron AL, Steinbach LS, LeBoit PE, Mills CM, Gee JH, Berger TG. Osteolytic lesions and bacillary angiomatosis in HIV infection: radiologic differentiation from AIDS-related Kaposi sarcoma. Radiology. 1990;177(1):77–81.PubMedCrossRef
50.
Fagan WA, DeCamp NC, Kraus EW, Pulitzer DR. Widespread cutaneous bacillary angiomatosis and a large fungating mass in an HIV-positive man. J Am Acad Dermatol. 1996;35(2 II):285–7.PubMedCrossRef
51.
Fagan WA, Skinner SM, Ondo A, Williams JT, Anthony K, DeVillez RL, Pulitzer DR. Bacillary angiomatosis of the skin and bone marrow in a patient with HIV infection. J Am Acad Dermatol. 1995;32(3):510–2.PubMedCrossRef
52.
Hettmannsperger U, Soehnchen R, Gollnick H, Detmar M, Orfanos CE. Bacillary epithelioid angiomatosis in advanced HIV infection. Hautarzt. 1993;44(12):803–7.PubMed
53.
Husain S, Singh N. Pyomyositis associated with bacillary angiomatosis in a patient with HIV infection. Infection. 2002;30(1):50–3.PubMedCrossRef
54.
Mateen FJ, Newstead JC, McClean KL. Bacillary angiomatosis in an HIV-positive man with multiple risk factors: a clinical and epidemiological puzzle. Can J Infect Dis Med Microbiol. 2005;16(4):249–52.PubMedPubMedCentralCrossRef
55.
Monteil RA, Michiels JF, Hofman P, Saint-Paul MC, Hitzig C, Perrin C, Santini J. Histological and ultrastructural study of one case of oral bacillary angiomatosis in HIV disease and review of the literature. Eur J Cancer Part B: Oral Oncol. 1994;30(1):65–71.CrossRef
56.
Murillo O, Mimbrera D, Petit A, Gil H, Anda P, Carrera M, Podzamczer D. Fatal bacillary angiomatosis mimicking an infiltrative vascular tumour in the immune restoration phase of an HIV-infected patient. Antivir Ther. 2012;17(2):405–7.PubMedCrossRef
57.
Plettenberg A, Lorenzen T, Burtsche BT, Rasokat H, Kaliebe T, Albrecht H, Mertenskotter T, Bogner JR, Stoehr A, Schofer H. Bacillary angiomatosis in HIV-infected patients–an epidemiological and clinical study. Dermatology. 2000;201(4):326–31.PubMedCrossRef
58.
Rodriguez O, Campbell LR, Bacha JM, Kovarik CL. Successful treatment of bacillary angiomatosis with oral doxycycline in an HIV-infected child with skin lesions mimicking Kaposi sarcoma. JAAD Case Rep. 2016;2(1):77–9.PubMedPubMedCentralCrossRef
59.
Brzewski P, Kwiecińska M, Sułowicz J, Podolec K, Obtułowicz A, Dyduch G, Wojas-Pelc A. Bacillary Angiomatosis in Renal Transplant recipient: a Case Report. Transpl Proc. 2020;52(8):2524–6.CrossRef
60.
Cline MS, Cummings OW, Goldman M, Filo RS, Pescovitz MD. Bacillary angiomatosis in a renal transplant recipient. Transplantation. 1999;67(2):296–8.PubMedCrossRef
61.
Dardenne S, Coche E, Weynand B, Poncelet A, Zech F, De Meyer M. High suspicion of Bacillary Angiomatosis in a kidney transplant recipient: a difficult way to diagnose-Case Report. Transpl Proc. 2007;39(1):311–3.CrossRef
62.
Eid R, Assayag M, Lefevre E, Escaut L, Laifi M, Brodin-Sartorius A, Zaidan M, Snanoudj R. Invasive bacillary angiomatosis in a kidney transplant recipient: a challenging case on belatacept immunosuppression. Int J Infect Dis. 2023;133:43–5.PubMedCrossRef
63.
Grabas M, Darrieux L, Potier J, Safa G. Hemophagocytic syndrome as the presenting manifestation of bacillary angiomatosis in a renal transplant recipient. J Am Acad Dermatol. 2012;67(5):e236–237.PubMedCrossRef
64.
65.
Juskevicius R, Vnencak-Jones C. Pathologic quiz case: a 17-year-old renal transplant patient with persistent fever, pancytopenia, and axillary lymphadenopathy. Bacillary angiomatosis of the lymph node in the renal transplant recipient. Arch Pathol Lab Med. 2004;128(1):e12–14.PubMedCrossRef
66.
Mehrmal S, Mhlaba JM, Zhou XA. Cutaneous bacillary angiomatosis in a renal transplant patient. Skinmed. 2021;19(2):150–4.PubMedPubMedCentral
67.
Morillas JA, Hassanein M, Syed B, Liaqat A, Bergfeld W, Sardiña LA, Fatica R, Lum J. Early post-transplant cutaneous bacillary angiomatosis in a kidney recipient: case report and review of the literature. Transpl Infect Disease 2021, 23(4).
68.
Orsag J, Flodr P, Melter O, Tkadlec J, Sternbersky J, Hruby M, Klicova A, Zamboch K, Krejci K, Zadrazil J. Cutaneous bacillary angiomatosis due to Bartonella quintana in a renal transplant recipient. Transpl Int. 2015;28(5):626–31.PubMedCrossRef
69.
Vetos D, Rickstrew J, Siscos S, Wang T. A case of bacillary angiomatosis following solid organ transplant. Int J Dermatol. 2022;61(7):e257–9.PubMedCrossRef
70.
Aydoǧan I, Parlak AH, Alper M, Aksoy KA. Bacillary angiomatosis in an HIV seronegative patient. Turkderm Deri Hastaliklari Ve Frengi Arsivi. 2004;38(1):71–4.
71.
Schwartz RA, Gallardo MA, Kapila R, Gascon P, Herscu J, Siegel I, Lambert WC. Bacillary angiomatosis in an HIV seronegative patient on systemic steroid therapy. Br J Dermatol. 1996;135(6):982–7.PubMedCrossRef
72.
Kreitzer T, Saoud A. Bacillary angiomatosis following the use of long-term methotrexate therapy: a case report. West Va Med J. 2006;102(1):317–8.
73.
Ye B, Liu X, Li X, Kong H, Tian L, Chen Y. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis. 2015;6(3):e1694.PubMedPubMedCentralCrossRef
74.
Rodriguez IJ, Lalinde Ruiz N, Llano Leon M, Martinez Enriquez L, Montilla Velasquez MDP, Ortiz Aguirre JP, Rodriguez Bohorquez OM, Velandia Vargas EA, Hernandez ED. Parra Lopez CA: Immunosenescence Study of T cells: a systematic review. Front Immunol. 2020;11:604591.PubMedCrossRef
75.
McCormick DW, Rassoulian-Barrett SL, Hoogestraat DR, Salipante SJ, SenGupta D, Dietrich EA, Cookson BT, Marx GE, Lieberman JA. Bartonella Spp. Infections identified by molecular methods, United States. Emerg Infect Dis. 2023;29(3):467–76.PubMedPubMedCentralCrossRef
76.
Meghari S, Rolain JM, Grau GE, Platt E, Barrassi L, Mege JL, Raoult D. Antiangiogenic effect of erythromycin: an in vitro model of Bartonella quintana infection. J Infect Dis. 2006;193(3):380–6.PubMedCrossRef
77.
Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho EM, Ephros M, Jeronimo S, Magill A. Diagnosis and treatment of Leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016;63(12):e202–64.PubMedCrossRef
78.
van Daalen KR, Romanello M, Rocklov J, Semenza JC, Tonne C, Markandya A, Dasandi N, Jankin S, Achebak H, Ballester J, et al. The 2022 Europe report of the Lancet countdown on health and climate change: towards a climate resilient future. Lancet Public Health. 2022;7(11):e942–65.PubMedPubMedCentralCrossRef
79.
Chinga-Alayo E, Huarcaya E, Nasarre C, del Aguila R, Llanos-Cuentas A. The influence of climate on the epidemiology of bartonellosis in Ancash, Peru. Trans R Soc Trop Med Hyg. 2004;98(2):116–24.PubMedCrossRef
80.
Silverman J, Rust MK, Reierson DA. Influence of temperature and humidity on survival and development of the cat flea, Ctenocephalides felis (Siphonaptera: Pulicidae). J Med Entomol. 1981;18(1):78–83.PubMedCrossRef
81.
Kokkinaki KCG, Saridomichelakis MN, Skampardonis V, Mataragka A, Ikonomopoulos J, Leontides L, Mylonakis ME, Steiner JM, Suchodolski JS, Xenoulis PG. Prevalence and risk factors for Bartonella spp. and Haemoplasma Infections in cats from Greece. Vet Sci 2022, 9(7).
82.
Sepulveda-Garcia P, Alabi A, Alvarez K, Rojas L, Mella A, Goncalves LR, Andre MR, Machado RZ, Muller A, Monti G. Bartonella spp. in households with cats: risk factors for infection in cats and human exposure. One Health. 2023;16:100545.PubMedPubMedCentralCrossRef
83.
Mitchell BM, Font RL. Molecular detection of bartonella henselae for the diagnosis of cat scratch disease and bacillary angiomatosis of the conjunctiva. Cornea. 2011;30(7):807–14.PubMedCrossRef
84.
Halos L, Mavris M, Vourc’h G, Maillard R, Barnouin J, Boulouis HJ, Vayssier-Taussat M. Broad-range PCR-TTGE for the first-line detection of bacterial pathogen DNA in ticks. Vet Res. 2006;37(2):245–53.PubMedCrossRef
85.
La Scola B, Liang Z, Zeaiter Z, Houpikian P, Grimont PA, Raoult D. Genotypic characteristics of two serotypes of Bartonella henselae. J Clin Microbiol. 2002;40(6):2002–8.PubMedPubMedCentralCrossRef
86.
Sala M, Font B, Sanfeliu I, Quesada M, Ponts I, Segura F. Bacillary angiomatosis caused by Bartonella quintana. Ann N Y Acad Sci. 2005;1063:302–7.PubMedCrossRef
87.
Mazzitelli M, Lamberti AG, Quirino A, Marascio N, Barreca GS, Costa C, Pisani V, Strazzulla A, Greco G, Liberto MC, et al. Utility of molecular identification and Quantitation of Bartonella Species with species-specific real-time PCR for monitoring treatment response: a Case Series. Open Microbiol J. 2018;12:148–53.PubMedPubMedCentralCrossRef
88.
Liberto MC, Lamberti AG, Marascio N, Matera G, Quirino A, Barreca GS, Baudi F, Foca A. Molecular identification of Bartonella quintana infection using species-specific real-time PCR targeting transcriptional regulatory protein (bqtR) gene. Mol Cell Probes. 2011;25(5–6):238–42.PubMedCrossRef
Metadata
Title
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment
Authors
Salvatore Rotundo
Maria Teresa Tassone
Nadia Marascio
Helen Linda Morrone
Simona Gigliotti
Angela Quirino
Alessandro Russo
Giovanni Matera
Enrico Maria Trecarichi
Carlo Torti
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09253-9

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue

Research

Diverse proinflammatory response in pharyngeal epithelial cells upon interaction with Neisseria meningitidis carriage and invasive isolates

Comment

A practical approach to screening for carbapenemase-producing Enterobacterales– views of a group of multidisciplinary experts from English hospitals

Research

Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda

Research

Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults

Research

Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015–2021

Research

Clostridioides difficile infection, recurrence and the associated healthcare consumption in Sweden between 2006 and 2019: a population-based cohort study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits